Evanson Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,316
Closed -$213K 306
2021
Q4
$213K Hold
2,316
0.02% 270
2021
Q3
$397K Sell
2,316
-14
-0.6% -$2.04K 0.04% 194
2021
Q2
$387K Sell
2,330
-65
-3% -$10.5K 0.04% 195
2021
Q1
$435K Sell
2,395
-3,221
-57% -$747K 0.06% 175
2020
Q4
$1.12M Buy
5,616
+59
+1% +$12K 0.18% 76
2020
Q3
$1.22M Hold
5,557
0.22% 61
2020
Q2
$1.06M Buy
5,557
+21
+0.4% +$3.68K 0.21% 66
2020
Q1
$858K Hold
5,536
0.2% 68
2019
Q4
$463K Hold
5,536
0.09% 129
2019
Q3
$375K Hold
5,536
0.08% 152
2019
Q2
$368K Hold
5,536
0.07% 158
2019
Q1
$308K Hold
5,536
0.06% 171
2018
Q4
$274K Hold
5,536
0.06% 177
2018
Q3
$478K Hold
5,536
0.1% 125
2018
Q2
$321K Hold
5,536
0.06% 183
2018
Q1
$223K Buy
+5,536
New +$209K 0.05% 229

Other funds holding TDOC

Evanson Asset Management's TDOC Position: Q1 2022 in Review

Evanson Asset Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,316 shares — an estimated $213K sold.

Evanson Asset Management first reported a position in TDOC in Q1 2018 and held it in 16 quarters. The position peaked at $1.22M in Q3 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Evanson Asset Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Evanson Asset Management sold 2,316 Teladoc Health shares in Q1 2022, an estimated $213K.
  • Evanson Asset Management first reported a position in Teladoc Health in Q1 2018 and held it in 16 quarters.
  • Evanson Asset Management's Teladoc Health position peaked at $1.22M in Q3 2020.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Evanson Asset Management's 13F filing for Q1 2022, filed 11 Apr 2022.